Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vipul Bhatia

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Combinatorial genetic strategy accelerates the discovery of cancer genotype-phenotype associationsShan Li, Alicia Wong, Huiyun Sun, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancerShan Li, Kai Song, Huiyun Sun, et al.
Nature Genetics|February 29, 2024
A combinatorial genetic strategy for exploring complex genotype-phenotype associations in cancerShan Li, Alicia Wong, Huiyun Sun, et al.
Nature Biomedical Engineering|October 22, 2025
Collagen-binding IL-12-armoured STEAP1 CAR-T cells reduce toxicity and treat prostate cancer in mouse modelsKoichi Sasaki, Vipul Bhatia, Yuta Asano, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
PGC-1α drives small cell neuroendocrine cancer progression towards an ASCL1-expressing subtype with increased mitochondrial capacityGrigor Varuzhanyan, Chia-Chun Chen, Jack Freeland, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2024
PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacityGrigor Varuzhanyan, Chia-Chun Chen, Jack Freeland, et al.
Nature Communications|April 11, 2023
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapyVipul Bhatia, Nikhil V Kamat, Tiffany E Pariva, et al.
JCI Insight|February 23, 2023
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancerErolcan Sayar, Radhika A Patel, Ilsa M Coleman, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Combinatorial genetic strategy accelerates the discovery of cancer genotype-phenotype associationsShan Li, Alicia Wong, Huiyun Sun, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancerShan Li, Kai Song, Huiyun Sun, et al.
Nature Genetics|February 29, 2024
A combinatorial genetic strategy for exploring complex genotype-phenotype associations in cancerShan Li, Alicia Wong, Huiyun Sun, et al.
Nature Biomedical Engineering|October 22, 2025
Collagen-binding IL-12-armoured STEAP1 CAR-T cells reduce toxicity and treat prostate cancer in mouse modelsKoichi Sasaki, Vipul Bhatia, Yuta Asano, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
PGC-1α drives small cell neuroendocrine cancer progression towards an ASCL1-expressing subtype with increased mitochondrial capacityGrigor Varuzhanyan, Chia-Chun Chen, Jack Freeland, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2024
PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacityGrigor Varuzhanyan, Chia-Chun Chen, Jack Freeland, et al.
Nature Communications|April 11, 2023
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapyVipul Bhatia, Nikhil V Kamat, Tiffany E Pariva, et al.
JCI Insight|February 23, 2023
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancerErolcan Sayar, Radhika A Patel, Ilsa M Coleman, et al.
Pageof 2